Advertisement

Bacterial infections and NSAIDs exposure? Seek septic complications

Published:March 13, 2017DOI:https://doi.org/10.1016/j.ejim.2017.03.004

      Abstract

      Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely consumed. Some authors suggested a relationship between more severe infections and NSAIDs exposure, especially skin and soft tissue infections (SSTI). However, their impact during bacterial infections remains unclear. The aim of the study was to report the severity features of patients having bacterial infection who were exposed to NSAIDs prior to their hospitalisation. Cases of infected patients with these characteristics declared to the pharmacovigilance department of a French university hospital from 1 January 2011 to 31 December 2013 were retrospectively reviewed.
      Forty-one patients were included, mainly male (61%). Median age was 37 years. No underlying disease was noted for 68% of cases. Ibuprofen was the most frequent drug (63%). Self-medication concerned 61% of cases. Respiratory tract, osteoarticular and SSTI were the most frequent infected sites. Patients suffered septic complications: dissemination of infection to more than one site (51%), suppuration (59%), and requirement for invasive procedures (32%). Eleven patients (27%) had severity criteria as usually defined (10 severe sepsis and 1 septic shock) and 30 did not. There was no significant difference regarding the rate of septic complications between the severe and non-severe group.
      Septic complications frequently occurred in patients with NSAIDs exposure, whether or not there was severe sepsis or shock. Further studies investigating the impact of NSAIDs in bacterial infections should consider the septic complications depicted here as clinically relevant endpoints. Moreover, clinicians should seek those complications in case of bacterial infections and NSAIDs use.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lamagni T.L.
        • Neal S.
        • Keshishian C.
        • Alhaddad N.
        • George R.
        • Duckworth G.
        • et al.
        Severe Streptococcus pyogenes infections, United Kingdom, 2003–2004.
        Emerg. Infect. Dis. 2008; 14: 202-209https://doi.org/10.3201/eid1402.070888
        • Stevens D.L.
        Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?.
        Clin. Infect. Dis. 1995; 21: 977-980
        • Legras A.
        • Giraudeau B.
        • Jonville-Bera A.-P.
        • Camus C.
        • François B.
        • Runge I.
        • et al.
        A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock.
        Crit. Care. 2009; 13: R43https://doi.org/10.1186/cc7766
        • Bone R.C.
        • Balk R.A.
        • Cerra F.B.
        • Dellinger R.P.
        • Fein A.M.
        • Knaus W.A.
        • et al.
        Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.
        Chest. 1992; 101: 1644-1655
        • Eisen D.P.
        Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis.
        Intensive Care Med. 2012; 38: 1249-1257https://doi.org/10.1007/s00134-012-2570-8
        • Basille D.
        • Plouvier N.
        • Trouve C.
        • Duhaut P.
        • Andrejak C.
        • Jounieaux V.
        Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia: a cohort study.
        Lung. 2016; https://doi.org/10.1007/s00408-016-9973-1
        • Lepelletier D.
        • Pinaud V.
        • Le Conte P.
        • Bourigault C.
        • Asseray N.
        • Ballereau F.
        • et al.
        Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case-control study.
        Eur. J. Clin. Microbiol. Infect. Dis. 2016; https://doi.org/10.1007/s10096-016-2770-1
        • Bryant A.E.
        • Bayer C.R.
        • Aldape M.J.
        • Stevens D.L.
        The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections.
        Curr. Opin. Infect. Dis. 2015; 28: 231-239https://doi.org/10.1097/QCO.0000000000000160
        • Singer M.
        • Deutschman C.S.
        • Seymour C.W.
        • Shankar-Hari M.
        • Annane D.
        • Bauer M.
        • et al.
        The third international consensus definitions for sepsis and septic shock (sepsis-3).
        JAMA. 2016; 315: 801-810https://doi.org/10.1001/jama.2016.0287